Tags

Current Alzheimer Research

 
Articles from the last few issues of Current Alzheimer Research © Bentham Science Publishers
 

The Path from Anti Parkinson Drug Selegiline and Rasagiline to Multifunctional Neuroprotective Anti Alzheimer Drugs Ladostigil and M30

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 5. (December 2006), pp. 541-550, doi:10.2174/156720506779025288
 

Foreword: Apoptotic Mechanisms in Neurodegenerative Diseases

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 4. (September 2006), pp. 267-267, doi:10.2174/156720506778249443
 

Molecular Insights into Mechanisms of the Cell Death Program:Role in the Progression of Neurodegenerative Disorders

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 4. (September 2006), pp. 269-283, doi:10.2174/156720506778249461
 

A Genomic Approach to Investigate Neuronal Apoptosis

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 4. (September 2006), pp. 285-296, doi:10.2174/156720506778249416
 

Role of Protein Conformational Dynamics and DNA Integrity in Relevance to Neuronal Cell Death in Neurodegeneration

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 4. (September 2006), pp. 297-309, doi:10.2174/156720506778249452
 

Role of Metals in Neuronal Apoptosis: Challenges Associated with Neurodegeneration

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 4. (September 2006), pp. 311-326, doi:10.2174/156720506778249399
 

Oxidative Stress: Apoptosis in Neuronal Injury

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 4. (September 2006), pp. 327-337, doi:10.2174/156720506778249515
 

Oxidative Stress, Mitochondrial Dysfunction, and Stress Signaling in Alzheimers Disease

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 4. (September 2006), pp. 339-349, doi:10.2174/156720506778249489
 

Molecular Mechanisms of Ischemic Neuronal Cell Death - With Relevance to Alzheimers Disease

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 4. (September 2006), pp. 351-358, doi:10.2174/156720506778249498
 

Amyloid Beta Peptide, 4-Hydroxynonenal and Apoptosis

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 4. (September 2006), pp. 359-364, doi:10.2174/156720506778249506
 

Genotoxicity in Alzheimers Disease: Role of Amyloid

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 4. (September 2006), pp. 365-375, doi:10.2174/156720506778249380
 

Challenges in Neuronal Apoptosis

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 4. (September 2006), pp. 377-391, doi:10.2174/156720506778249434
 

Apoptosis in Alzheimer Disease: A Mathematical Improbability

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 4. (September 2006), pp. 393-396, doi:10.2174/156720506778249470
 

A Commentary on Neuronal Degeneration and Cell Death in Guam ALS and PD: An Evolutionary Process of Understanding

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 4. (September 2006), pp. 397-401, doi:10.2174/156720506778249425
 

Histone Deacetylase Inhibitors: A Novel Therapeutic Approach to Huntingtons Disease (Complex Mechanism of Neuronal Death).

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 4. (September 2006), pp. 403-408, doi:10.2174/156720506778249407
 

Partnerships Between Philanthropy, Government and Investors are Needed to Advance Drug Discovery for Neurodegenerative Diseases

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 3. (July 2006), pp. 175-176, doi:10.2174/156720506777632853
 

Treatment of Alzheimers Disease: The Beginning of a New Era Dale Schenk, ISOA - October 5th-6th, 2005

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 3. (July 2006), pp. 177-177, doi:10.2174/156720506777632907
 

Fibrillar -Amyloid Impairs the Late Phase of Long Term Potentiation

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 3. (July 2006), pp. 179-183, doi:10.2174/156720506777632871
 

Therapeutic Potential of Neurogenesis for Prevention and Recovery from Alzheimers Disease: Allopregnanolone as a Proof of Concept Neurogenic Agent

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 3. (July 2006), pp. 185-190, doi:10.2174/156720506777632817
 

TGF- Pathway as a Potential Target in Neurodegeneration and Alzheimers

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 3. (July 2006), pp. 191-195, doi:10.2174/156720506777632916
 

Neurotrophic Effects of the Peptide NAP: A Novel Neuroprotective Drug Candidate

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 3. (July 2006), pp. 197-199, doi:10.2174/156720506777632790
 

The Pharmacology of Aminoadamantane Nitrates

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 3. (July 2006), pp. 201-204, doi:10.2174/156720506777632808
 

De Novo and Molecular Target-Independent Discovery of Orally Bioavailable Lead Compounds for Neurological Disorders

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 3. (July 2006), pp. 205-214, doi:10.2174/156720506777632844
 

Ongoing In Vivo Studies with Cytoskeletal Drugs in Tau Transgenic Mice

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 3. (July 2006), pp. 215-219, doi:10.2174/156720506777632880
 

RNA Therapeutics Directed to the Non Coding Regions of APP mRNA, In Vivo Anti-Amyloid Efficacy of Paroxetine, Erythromycin, and N-acetyl cysteine

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 3. (July 2006), pp. 221-227, doi:10.2174/156720506777632835
 

Autoimmunity in Alzheimers Disease as Evidenced by Plasma Immunoreactivity Against RAGE and A42: Complication of Diabetes

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 3. (July 2006), pp. 229-235, doi:10.2174/156720506777632899
 

NO Chimeras as Therapeutic Agents in Alzheimers Disease

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 3. (July 2006), pp. 237-245, doi:10.2174/156720506777632925
 

Computational Models of the Hippocampal Region: Implications for Prediction of Risk for Alzheimers Disease in Non-demented Elderly

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 3. (July 2006), pp. 247-257, doi:10.2174/156720506777632826
 

Lipophilic Analogs of Thioflavin S as Novel Amyloid-Imaging Agents

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 3. (July 2006), pp. 259-266, doi:10.2174/156720506777632862
 

Editorial- Update on Current Alzheimer Research

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 2. (April 2006), pp. 93-94, doi:10.2174/156720506776383040
 

Vicious Cycles Within the Neuropathophysiologic Mechanisms of Alzheimers Disease

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 2. (April 2006), pp. 95-107, doi:10.2174/156720506776383068
 

Alzheimers Disease - An Interactive Perspective

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 2. (April 2006), pp. 109-121, doi:10.2174/156720506776383022
 

Inhibition of GSK3 Dependent Tau Phosphorylation by Metals

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 2. (April 2006), pp. 123-127, doi:10.2174/156720506776383059
 

Treating Alzheimers Disease by Inactivating Bioactive Amyloid Peptide

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 2. (April 2006), pp. 129-135, doi:10.2174/156720506776383077
 

Pharmacological Manipulation of the Vasoconstrictive Effects of Amyloid- Peptides by Donepezil and Rivastigmine

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 2. (April 2006), pp. 137-145, doi:10.2174/156720506776383086
 

Cholinesterase Inhibitors Slow Decline in Executive Functions, Rather than Memory, in Alzheimers Disease: A 1-Year Observational Study in the Sunnybrook Dementia Cohort

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 2. (April 2006), pp. 147-156, doi:10.2174/156720506776383031
 

Studies on the Effect of the Apolipoprotein E Genotype on the Lipid Profile in Alzheimers Disease

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 2. (April 2006), pp. 157-160, doi:10.2174/156720506776383013
 

Predictors of Conversion to Dementia of Probable Alzheimer Type in Patients with Mild Cognitive Impairment

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 2. (April 2006), pp. 161-170, doi:10.2174/156720506776383103
 

Commentary ( The Renin Angiotensin System in Alzheimers Disease - Do Updates Highlight a Clinical and Biological Dichotomy? )

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 2. (April 2006), pp. 171-173, doi:10.2174/156720506776383095
 

Editorial - A Milestone for Current Alzheimer Research [Hot Topic: Neurogenesis Catalyst Conference (Guest Editors: Howard M. Fillit Gunnar Gouras) ]

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 1. (February 2006), pp. 1-1, doi:10.2174/156720506775697115
 

Neurogenesis as a Therapeutic Strategy for Cognitive Aging and Alzheimers Disease

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 1. (February 2006), pp. 3-3, doi:10.2174/156720506775697151
 

Small Molecule Approaches for Promoting Neurogenesis

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 1. (February 2006), pp. 5-10, doi:10.2174/156720506775697089
 

Preclinical Analyses of the Therapeutic Potential of Allopregnanolone to Promote Neurogenesis In Vitro and In Vivo in Transgenic Mouse Model of Alzheimers Disease

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 1. (February 2006), pp. 11-17, doi:10.2174/156720506775697160
 

Dissecting the Diverse Actions of Pro- and Mature Neurotrophins

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 1. (February 2006), pp. 19-24, doi:10.2174/156720506775697061
 

Neurodegeneration and Neurogenesis: Focus on Alzheimers Disease

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 1. (February 2006), pp. 25-28, doi:10.2174/156720506775697106
 

VEGF, a Mediator of the Effect of Experience on Hippocampal Neurogenesis

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 1. (February 2006), pp. 29-33, doi:10.2174/156720506775697133
 

Effects of Paliroden (SR57667B) and Xaliproden on Adult Brain Neurogenesis

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 1. (February 2006), pp. 35-36, doi:10.2174/156720506775697070
 

Implications for CNS Repair of Redox Modulation of Cell Survival, Division and Differentiation

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 1. (February 2006), pp. 37-47, doi:10.2174/156720506775697188
 

Environment, Physical Activity, and Neurogenesis: Implications for Prevention and Treatment of Alzhemiers Disease

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 1. (February 2006), pp. 49-54, doi:10.2174/156720506775697197
 

Discovery of Neurogenic, Alzheimers Disease Therapeutics

  [CiTO]
Current Alzheimer Research, Vol. 3, No. 1. (February 2006), pp. 55-62, doi:10.2174/156720506775697179

Result page: Previous 5 6 7 8 9 10 11 Next

Create CiTO

Create a CiTO relationship by dragging the [CiTO] link onto another article.

Alternatively, drag two articles into the two boxes below. This is useful when the two articles are not on the same page - the articles will be remembered between pages.

This article...

...this one

Privacy Statement | Terms & Conditions
CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.